Article Text

Download PDFPDF
P89 Implementation of a nationwide guideline to detect of women at risk for Lynch syndrome in endometrial cancer should be improved
  1. AS Tjalsma1,
  2. A Wagner2,
  3. WNM Dinjens3,
  4. PC Ewing-Graham4 and
  5. HC Van Doorn5
  1. 1Gynaecology, Erasmus MC Cancer Clinic
  2. 2Clinical Genetics, Erasmus Medical Centre, Rotterdam
  3. 3Pathology, Erasmus Medical Centre, Ro
  4. 4Pathology, Erasmus Medical Centre, Rotterdam
  5. 5Gynaecology, Erasmus MC Cancer Clinic, R, The Netherlands


Introduction/Background Since 2016 routine Lynch syndrome screening (LSS) among women with endometrial cancer <70 years of age has been incorporated in a nationwide guideline. LSS consists of immunohistochemical (IHC) staining for loss of miss match repair (MMR) protein expression, extended with methylation analysis of the MLH1 promotor in case of MLH1 and PMS2 loss. Test results are discussed by the treating gynaecologist, who refers patients to a genetic counsellor (figure 1).

Objective Evaluate the implementation of the Dutch guideline to screen women with endometrial carcinoma under the age of 70 years for Lynch syndrome.

Methodology From the pathology database women diagnosed with EC <70 years of age, treated from 1.6.2016 - 1.6.2017, in 14 hospitals, covering about 30% of the Netherlands, were selected. Data collected regarded LS testing and outcome, and follow up. The study was approved by the institutional review boards of participating hospitals.

Results In 184 out of the 205 tumours (90%) LSS was performed (table 1). Either on the endometrial biopsy 24%, the hysterectomy (70%), or on both (6%). In 42 cases (22%) MMR protein expression was lost, in 25 cases due to hypermethylation of the MLH1 promotor. LS susceptibility was discussed with 11 of the 17 patients at risk of LS (65%), all were referred for genetic counselling. Three of them declined; eight underwent germline testing for LS after counselling. In one no germline mutation was detected, two were diagnosed with a PMS2 mutation, and five with a MSH6 mutation.

Conclusion The implementation of the guideline regarding LSS has been successful, though referral for genetic counselling should be improved. Gynaecologist ought to be aware of the benefits and drawbacks of knowing mutational status, and may require training in discussing this with their patients.

Disclosure Nothing to disclose.

Abstract P89 Table 1


Abstract P89 Figure 1

Nationwide dutch guideline for detecting lynch syndrome (LS) in women with endometrial cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.